NEWTOWN, Pa.--(BUSINESS WIRE)--
Onconova Therapeutics, Inc., today announced the pricing of its initial
public offering of 5,166,667 shares of its common stock at a public
offering price of $15.00 per share, before underwriting discounts. All
of the shares of common stock are being offered by Onconova. In
addition, Onconova has granted the underwriters a 30-day option to
purchase up to an additional 775,000 shares of common stock at the same
price to cover over-allotments, if any. The shares are expected to begin
trading on The NASDAQ Global Market on July 25, 2013 under the ticker
symbol "ONTX."
The offering is expected to close on July 30, 2013, subject to customary
closing conditions.
Citigroup
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in